Astellas Skirts $867M Antitrust Suit Over Heart Test Drug
By Bill Donahue ( September 26, 2012, 3:45 PM EDT) -- A federal judge ruled Monday that a Florida hospital didn't have standing to file an $867 million antitrust class action accusing Astellas Pharma Inc. of abusing a patent monopoly to force health care providers to use only an Astellas-brand cardiac testing drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.